Homicidal ideation (HI) refers to thoughts, fantasies, or plans about killing or causing serious harm to another person. It exists on a spectrum from passive, fleeting thoughts to active ideation with a specific plan, identified target, and intent to act. HI is a psychiatric emergency that requires immediate safety assessment, risk stratification, and determination of the underlying etiology. [1-3]
1. History
- Nature of ideation: Passive thoughts vs. active planning; ego-syntonic vs. ego-dystonic; intrusive/unwanted vs. deliberate
- Specificity: Is there an identified target? A specific plan? Access to means (firearms, weapons, medications)?
- Frequency, intensity, duration: How often do the thoughts occur? Are they escalating?
- Triggers: Interpersonal conflict, perceived threat, paranoia, command hallucinations, substance use, recent loss or humiliation
- Intent and perceived ability to act: Does the patient intend to carry out the thoughts? Do they believe they could?
- Prior violence history: Past assaults, arrests, restraining orders, animal cruelty, property destruction
- Concurrent suicidal ideation: ~67–77% of patients with HI also endorse suicidal ideation — always screen for both [4-5]
- Substance use: Acute intoxication or withdrawal (alcohol, stimulants, PCP, synthetic cannabinoids)
- Psychotic symptoms: Paranoid delusions, command auditory hallucinations to harm others, persecutory beliefs [2][6]
- Recent stressors: Job loss, relationship breakdown, legal problems, financial instability
2. Alarm Features
- Specific, named target with an organized plan [1][5]
- Access to firearms or other lethal means [1][7]
- Command hallucinations directing harm to others [2][6]
- Active psychosis with paranoid or persecutory delusions
- History of prior violent acts or homicide attempts
- Concurrent suicidal ideation with plan/intent
- Acute intoxication (especially stimulants, PCP, alcohol)
- Escalating agitation, threatening behavior, or inability to be redirected
- Recent acquisition of weapons or surveillance of a target
- Statements of "nothing to lose" or nihilistic thinking
3. Medications
Medications that may contribute to HI or aggression
- Stimulants (prescribed or illicit), corticosteroids, anticholinergics, dopamine agonists
- Paradoxical reactions to benzodiazepines (especially in elderly, brain-injured, or personality-disordered patients)
- SSRI/SNRI initiation (rare; more commonly associated with suicidality in youth, but agitation/akathisia can occur)
- Medication non-adherence in patients with psychotic or bipolar disorders is a major risk factor for violence [8]
Acute pharmacologic management of agitation
- First-line oral: Olanzapine 5–10 mg, lorazepam 1–2 mg, or haloperidol 5 mg + lorazepam 2 mg [9-10]
- First-line IM: Olanzapine 10 mg IM, haloperidol 5 mg + promethazine 25–50 mg IM, or droperidol 5–10 mg IM [9][11]
- Second-line/rescue: Midazolam 5 mg IM (fastest onset but risk of respiratory depression); ketamine 2–5 mg/kg IM reserved for severe agitation refractory to first-line agents [12-13]
- Do not combine IM olanzapine and IM benzodiazepines (risk of cardiorespiratory depression)
Longer-term treatment is directed at the underlying psychiatric disorder (antipsychotics for psychosis, mood stabilizers for bipolar disorder, etc.)
4. Diet
- Not a primary consideration in acute management
- Alcohol and substance use are major modifiable contributors — counsel on cessation
- Caffeine excess may worsen agitation and insomnia in susceptible patients
- Ensure adequate nutrition and hydration during psychiatric holds, especially if patient is restrained or sedated
5. Review of Systems
- Psychiatric: Hallucinations (especially command type), delusions, paranoia, mood symptoms, sleep disturbance, anhedonia, mania symptoms (grandiosity, decreased sleep, pressured speech)
- Neurologic: Headache, seizures, focal deficits, confusion, altered consciousness (consider delirium, intracranial pathology)
- Substance use: Recent alcohol, stimulant, hallucinogen, PCP, synthetic cannabinoid, or opioid use; withdrawal symptoms
- Endocrine: Thyroid symptoms, adrenal dysfunction
- Infectious: Fever, meningismus, altered mental status (consider encephalitis, neurosyphilis, HIV) [14]
- Trauma: Recent head injury
6. Collateral History and Family History
- Collateral is essential — obtain information from family, friends, law enforcement, prior medical records, and outpatient providers [6]
- Prior psychiatric hospitalizations, medication compliance, baseline functioning
- Family history of psychiatric illness (schizophrenia, bipolar disorder, antisocial personality disorder), violence, or suicide
- History of childhood abuse, neglect, or exposure to domestic violence
- Social context: housing instability, isolation, access to weapons, involvement with the criminal justice system
- Presence of a Psychiatric Advance Directive [15]
7. Risk Factors
Based on the APA Resource Document on Violence Risk Assessment and large epidemiologic studies: [1][3][6][8]
- Strongest psychiatric associations: Antisocial personality disorder (OR ~24x), schizoaffective disorder (OR ~18x), borderline personality disorder (OR ~16x), paranoid personality disorder (OR ~15x), schizophrenia (OR ~11x) [3]
- Substance/alcohol use disorders — the single most consistent risk factor across studies [8][16]
- Comorbid psychiatric diagnoses — comorbidity multiplicatively increases risk [16]
- Prior history of violence — strongest individual predictor [6][8]
- Male sex, younger age [1][4]
- Command hallucinations to harm others [6]
- Medication non-adherence [8]
- Access to firearms or weapons [1]
- Acute psychosis, especially first episode or acute exacerbation [8]
- Recent psychosocial stressors: relationship breakdown, job loss, legal problems, isolation [1]
- Traumatic brain injury, intellectual disability, neurodevelopmental disorders
8. Differential Diagnosis
The differential focuses on identifying the underlying etiology driving HI:
- Psychotic disorders: Schizophrenia, schizoaffective disorder, brief psychotic disorder, delusional disorder [3][17]
- Mood disorders: Bipolar disorder (manic or mixed episodes), major depressive disorder with psychotic features [4][18]
- Personality disorders: Antisocial, borderline, paranoid [3]
- Substance intoxication/withdrawal: Stimulants (methamphetamine, cocaine), PCP, alcohol, synthetic cannabinoids, hallucinogens [14][17]
- Delirium: Medical, metabolic, infectious, or toxic etiologies — must be ruled out before attributing to primary psychiatric illness [2]
- Traumatic brain injury / neurologic conditions: Frontal lobe lesions, seizure disorders, encephalitis, brain tumors [14]
- Conduct disorder / ADHD (in adolescents) [4]
- PTSD with hyperarousal and dissociation
- Malingering / factitious disorder: Particularly in forensic or secondary-gain contexts [17]
- Medical causes of psychosis: Thyroid disorders, Cushing syndrome, Wilson disease, autoimmune encephalitis, neurosyphilis, HIV [14]
9. Past Medical History
- Prior psychiatric diagnoses and hospitalizations
- Previous episodes of violence, aggression, or homicidal ideation
- History of suicide attempts (high co-occurrence with HI) [5]
- Substance use disorder history
- Traumatic brain injury or seizure disorder
- Chronic pain conditions (may contribute to frustration, desperation)
- Legal history: arrests, incarcerations, restraining orders
- Medication history and adherence patterns
10. Physical Exam
- Vital signs: Tachycardia, hypertension, hyperthermia (consider sympathomimetic intoxication, neuroleptic malignant syndrome, excited delirium)
- General: Level of agitation (use a standardized scale), psychomotor activity, diaphoresis, tremor
- Neurologic: Mental status (orientation, attention, cognition — screen for delirium), pupil size and reactivity, focal deficits, gait abnormalities
- Skin: Track marks, signs of self-harm, diaphoresis
- Head/face: Signs of trauma
- Focused exam maneuvers: Assess for stigmata of liver disease (alcohol use), thyromegaly, Kayser-Fleischer rings (Wilson disease)
- Safety: Perform exam with door open, security nearby; search for weapons or contraband per institutional protocol [15][19]
11. Lab Studies
The ACEP Clinical Policy (2017) does not recommend routine labs for all psychiatric patients but supports targeted testing based on clinical presentation: [13]
- Blood glucose — hypoglycemia can mimic psychiatric symptoms
- Urine drug screen — essential to identify substance-related etiologies
- Blood alcohol level
- Basic metabolic panel — electrolyte abnormalities, renal function
- CBC — infection screening
- Thyroid function tests — if new-onset psychosis or mood symptoms
- Hepatic panel — if substance use or medication toxicity suspected
- Urinalysis — UTI as cause of delirium (especially elderly)
- Serum medication levels (lithium, valproic acid, etc.) if applicable
- RPR/VDRL, HIV — if new-onset psychosis [14]
- Ammonia — if hepatic encephalopathy suspected
- Creatine kinase — if prolonged agitation, restraint use, or concern for rhabdomyolysis
12. Imaging
- CT head without contrast: Indicated for new-onset psychosis, focal neurologic deficits, altered mental status, or history of head trauma. The ACEP Clinical Policy states that neuroimaging is not routinely required for patients with known psychiatric illness and no focal deficits [13]
- MRI brain: Gold standard for structural pathology (tumors, demyelination, encephalitis) — obtain if CT is non-diagnostic and clinical suspicion remains
- Imaging is unnecessary in patients with known psychiatric illness presenting with their typical symptoms and a normal neurologic exam
13. Special Tests
- Violence risk assessment tools: Structured instruments include the HCR-20 (Historical, Clinical, Risk Management), VRAG (Violence Risk Appraisal Guide), and OxMIV (Oxford Mental Illness and Violence tool). These supplement but do not replace clinical judgment [8][20-21]
- Columbia Suicide Severity Rating Scale (C-SSRS): Given high co-occurrence of suicidal and homicidal ideation [19][22]
- Agitation severity scales: PANSS-EC (Positive and Negative Syndrome Scale – Excited Component), ACES (Agitation-Calmness Evaluation Scale), Behavioral Activity Rating Scale [9]
- Lumbar puncture: If encephalitis or meningitis is suspected
- EEG: If seizure disorder is in the differential
14. ECG
- Obtain baseline ECG before administering antipsychotics, particularly haloperidol and droperidol, due to risk of QTc prolongation and torsades de pointes [12]
- Monitor QTc if using multiple QT-prolonging agents
- ECG also indicated if sympathomimetic intoxication is suspected (cocaine, methamphetamine — assess for ischemia, dysrhythmia)
- Dangerous patterns: Prolonged QTc (>500 ms), Brugada pattern, wide-complex tachycardia
15. Assessment
Severity stratification — the key clinical decision is determining the imminence and specificity of the threat: [1][23]
- 66.9% of adolescents and ~77% of adults with HI also have concurrent suicidal ideation — always assess both [4-5]
- 85% of patients making homicidal threats have a previously documented psychiatric disorder [5]
- 60% of homicidal patients in one ED study had unrelated medical disorders requiring intervention — do not overlook medical comorbidities [5]
16. Treatment Plan
Immediate stabilization
- Ensure scene safety: security presence, remove potential weapons, 1:1 monitoring [15][19]
- Verbal de-escalation is first-line — project calm, maintain safe distance, avoid confrontation, offer choices [15][24]
- If de-escalation fails, offer voluntary oral medication before parenteral agents [15]
- If patient refuses or is severely agitated: rapid tranquilization per protocols above (see Medications section) [9-10]
- Physical restraints as last resort only when less restrictive measures have failed; continuous monitoring required [15]
Duty to warn/protect (Tarasoff)
- In ~33 US jurisdictions, clinicians have a legal duty to protect identifiable potential victims when a patient makes a credible, specific threat [25-26]
- Actions may include: warning the intended victim, notifying law enforcement, involuntary hospitalization [23]
- Document thoroughly: risk factors assessed, clinical reasoning, actions taken, and rationale [27]
- Know state-specific laws — requirements vary significantly [28-29]
Lethal means restriction
- Assess access to firearms, weapons, and potentially lethal medications [1][7]
- Counsel family on securing or removing firearms; consider Extreme Risk Protection Orders (ERPOs) where available [30]
Treat the underlying condition
- Psychosis → antipsychotics
- Bipolar mania → mood stabilizers ± antipsychotics
- Substance intoxication → supportive care, observation
- Delirium → identify and treat the underlying cause
- Personality disorders → crisis intervention, safety planning, outpatient DBT/CBT referral
17. Disposition
Admit (involuntary hold if necessary)
- Specific, credible threat with identified target and plan [1-2]
- Active psychosis with command hallucinations to harm others [2]
- Inability to contract for safety or cooperate with outpatient plan
- Concurrent high-risk suicidal ideation
- Acute intoxication with persistent HI after sobering
- No adequate outpatient support or follow-up available [31]
Observation
- Substance-related HI that may resolve with sobriety
- Vague ideation without plan, pending psychiatric evaluation
Discharge (with safety plan)
- Fleeting, ego-dystonic thoughts without plan, target, or intent
- Strong protective factors (social support, engaged in treatment, no access to means)
- Reliable outpatient psychiatric follow-up confirmed
- Lethal means counseling completed and documented
Specialist consultation triggers
- Psychiatry consultation for all patients with HI in the ED [2]
- Forensic psychiatry if medicolegal complexity (Tarasoff obligations, competency questions)
- Social work for safety planning, family support, and resource coordination
18. Follow Up / Return Precautions
- Follow-up timing: Outpatient psychiatric follow-up within 24–72 hours of discharge for any patient with HI
- Return precautions — instruct patient and family to return immediately for:
- Worsening or new homicidal thoughts
- Development of a specific plan or target
- Acquisition of weapons
- Escalating agitation, aggression, or psychotic symptoms
- New or worsening suicidal ideation
- Medication non-adherence or adverse effects
- Patient/family counseling: Educate on the importance of medication adherence, substance avoidance, and crisis resources (988 Suicide & Crisis Lifeline, local crisis teams) [1]
- Expected course: Prognosis depends on the underlying diagnosis and treatment engagement; patients with substance-related HI who achieve sobriety and those with medication-responsive psychosis generally have favorable short-term outcomes with appropriate treatment [18]
- Safety planning: Written crisis plan including emergency contacts, coping strategies, and means restriction steps
References
1. Survivorship. — Updated 2026-04-08. National Comprehensive Cancer Network.
2. Management of First-Episode Psychosis and Schizophrenia (SCZ) (2023). — Marlene Arias-Reynoso DNP PMHNP-BC, Jennifer L. Bell MD, Pamela Blueford LICSW, et al Department of Veterans Affairs. 2023.
3. Homicidal Ideation and Forensic Psychopathology: Evidence From the 2016 Nationwide Emergency Department Sample (NEDS). — Carbone JT, Holzer KJ, Vaughn MG, DeLisi M. Journal of Forensic Sciences. 2020.
4. Homicidal Ideation and Psychiatric Comorbidities in the Inpatient Adolescents Aged 12-17. — Sun CF, Mansuri Z, Trivedi C, Vadukapuram R, Reddy A. Frontiers in Psychiatry. 2022.
5. Patients Threatening Harm to Others Evaluated in the Emergency Department Under the Florida Involuntary Hold Act (Baker Act). — Maniaci MJ, Burton MC, Lachner C, et al. Southern Medical Journal. 2019.
6. Psychiatric violence risk assessment. — Alec Buchanan MD PhD, Renee Binder MD, Michael Norko MD, Marvin Swartz MD American Psychiatric Association (2011). 2011.
7. Resource Document on Risk-Based Gun Removal Laws. — Reena Kapoor MD, Elissa Benedek MD, Richard J. Bonnie LLB, et al American Psychiatric Association (2018). 2018.
8. Violence and Mental Disorders: A Structured Review of Associations by Individual Diagnoses, Risk Factors, and Risk Assessment. — Whiting D, Lichtenstein P, Fazel S. The Lancet. Psychiatry. 2021.
9. "Pharmacological Management of Acute Agitation in Psychiatric Patients: An Umbrella Review". — Uribe ES, Rodríguez CAB, Juárez MEN, et al. BMC Psychiatry. 2025.
10. Psychopharmacology of Agitation in Acute Psychotic and Manic Episodes. — Stetson SR, Osser DN. Current Opinion in Psychiatry. 2022.
11. The Pharmacological Management of Agitated and Aggressive Behaviour: A Systematic Review and Meta-Analysis. — Bak M, Weltens I, Bervoets C, et al. European Psychiatry : The Journal of the Association of European Psychiatrists. 2019.
12. Safety and Efficacy of Pharmacologic Agents Used for Rapid Tranquilization of Emergency Department Patients With Acute Agitation or Excited Delirium. — Kim HK, Leonard JB, Corwell BN, Connors NJ. Expert Opinion on Drug Safety. 2021.
13. Clinical Policy: Critical Issues in the Diagnosis And Management of the Adult Psychiatric Patient In the Emergency Department. — Nazarian DJ, Broder JS, Thiessen MEW, et al. Annals of Emergency Medicine. 2017.
14. Collaborative Care in the Identification and Management of Psychosis in Adolescents and Young Adults. — Hua LL. Pediatrics. 2021.
15. Seclusion or Restraint. — American Psychiatric Association (2022). 2022.
16. Violence and Homicidal Behaviors in Psychiatric Disorders. — Asnis GM, Kaplan ML, Hundorfean G, Saeed W. The Psychiatric Clinics of North America. 1997.
17. Diagnostic and Statistical Manual of Mental Disorders. — Dilip V. Jeste, Jeffrey A. Lieberman, David Fassler, et al American Psychiatric Association (2022). 2022.
18. Prevention of Homicidal Behaviour in Men With Psychiatric Disorders. — Sher L, Rice T. The World Journal of Biological Psychiatry : The Official Journal of the World Federation of Societies of Biological Psychiatry. 2015.
19. The Management of Children and Youth With Pediatric Mental and Behavioral Health Emergencies. — Saidinejad M, Duffy S, Wallin D, et al. Pediatrics. 2023.
20. Evaluating the Risk of Suicide and Violence in Severe Mental Illness: A Feasibility Study of Two Risk Assessment Tools (OxMIS and OxMIV) in General Psychiatric Settings. — Beaudry G, Canal-Rivero M, Ou J, et al. Frontiers in Psychiatry. 2022.
21. Risk Assessment for Aggressive Behaviour in Schizophrenia. — Välimäki M, Lantta T, Kontio R. The Cochrane Database of Systematic Reviews. 2024.
22. Management of Bipolar Disorder (BD) (2023). — Thad Abrams MD MS, Jennifer Bell MD, Paulette Cazares MD MPH, et al Department of Veterans Affairs. 2023.
23. The Clinician's Duty to Protect Third Parties. — Felthous AR. The Psychiatric Clinics of North America. 1999.
24. De-Escalation Techniques for Managing Non-Psychosis Induced Aggression in Adults. — Spencer S, Johnson P, Smith IC. The Cochrane Database of Systematic Reviews. 2018.
25. Protecting Victims of Violent Patients While Protecting Confidentiality. — Bersoff DN. The American Psychologist. 2014.
26. The Psychiatrist's Duty to Protect. — Knoll JL. CNS Spectrums. 2015.
27. Legal Issues in Treating Perpetrators and Victims of Violence. — Resnick PJ, Scott CL. The Psychiatric Clinics of North America. 1997.
28. Tarasoff in Missouri: The Jurisprudence of a Mental Health Provider's Duty to Warn and Protect Non-Patients of Potential Risks From Patients. — Boulos N, Mallela D, Felthous A. Journal of Forensic Sciences. 2023.
29. How Specific Is the Specificity Rule in Duty to Warn or Protect Jurisprudence Following the Pennsylvania Supreme Court's Maas Decision?. — Radley A, Felthous AR. Journal of Forensic Sciences. 2025.
30. Clinical Approaches to the Prevention of Firearm-Related Injury. — Carter PM, Cunningham RM. The New England Journal of Medicine. 2024.
31. Decisions to Initiate Involuntary Commitment: The Role of Intensive Community Services and Other Factors. — McGarvey EL, Leon-Verdin M, Wanchek TN, Bonnie RJ. Psychiatric Services. 2013.